SanegeneBio is a privately held biotechnology company operating in the genetic and molecular biology domain, with a focus on research-stage platform technologies and services for life-science research, diagnostics, or therapeutic discovery. Publicly available, verifiable information about the company’s specific products, technology, and leadership is limited or not accessible from primary sources within the last six months.
Leadership & Board
Current Number of Employees34
Current LinkedIn Followers4,363
Latest Estimated Valuation
Estimated Valuation―
Estimated Valuation―
Total Amount Raised$80M
Total Amount Raised$80M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$80M
Latest Funding Amount$80M
Latest Funding RoundSeries A
Latest Funding RoundSeries A
Post-Money Valuation―
Post-Money Valuation―
Employee Trend
SanegeneBio had 34 employees as of September 7, 2026. The number of employees increased by 0 (0.00%) week-over-week.
34Latest Employee Count
0(0.00%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.
Social Trend
SanegeneBio had 4,363 followers as of September 7, 2026. The number of followers increased by 17 (0.39%) week-over-week.
4,363Latest Followers Count
17(0.39%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.